Your browser doesn't support javascript.
loading
Patient Decision-Making About Self-Disclosure of a Type 2 Diabetes Diagnosis: A Qualitative Study.
Ledford, Christy J W; Villareal, Charisse; Williams, Elizabeth W; Cafferty, Lauren A; Jackson, Jeremy T; Seehusen, Dean A.
Afiliação
  • Ledford CJW; Department of Family Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD.
  • Villareal C; Department of Family Medicine, Medical College of Georgia, Augusta University, Augusta, GA.
  • Williams EW; National Capital Consortium Family Medicine Residency, Fort Belvoir, VA.
  • Cafferty LA; Eglin Family Medicine Residency, Eglin Air Force Base, FL.
  • Jackson JT; Department of Family Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD.
  • Seehusen DA; Military Primary Care Research Network, Bethesda, MD.
Diabetes Spectr ; 35(3): 327-334, 2022.
Article em En | MEDLINE | ID: mdl-36082012
ABSTRACT

Background:

Effective self-management of type 2 diabetes requires receiving support, which can result from disclosing the diagnosis to a support network, including coworkers, family, and friends. As a primarily invisible disease, diabetes allows people to choose whether to disclose. This study qualitatively explores the factors that influence a person's decision to disclose diabetes to others.

Methods:

Research coordinators recruited 22 interview participants, ranging in age from 32 to 64 years, whose medical records included a diagnosis code for type 2 diabetes. Participants received care from one of two U.S. medical centers. Semi-structured interviews lasted approximately 1 hour and were audio-recorded and professionally transcribed. Verification strategies such as memo-keeping and maintaining methodological coherence/congruence were used throughout analysis to promote rigor.

Results:

In patients' descriptions of their decision-making processes regarding whether to disclose their diagnosis, six themes emerged. Three motivations prompted open disclosure 1) to seek information, 2) to seek social support, and 3) to end the succession of diabetes, and the other three motivations prompted guarded disclosure 4) to prepare for an emergency, 5) to maintain an image of health, and 6) to protect employment.

Conclusion:

Based on our findings, we recommend three communicative actions for clinicians as they talk to patients about a diabetes diagnosis. First, clinicians should talk about the benefits of disclosure. Second, they should directly address stereotypes in an effort to de-stigmatize diabetes. Finally, clinicians can teach the skills of disclosure. As disclosure efficacy increases, a person's likelihood to disclose also increases. Individuals can use communication as a tool to gain the knowledge and support they need for diabetes self-management and to interrupt the continuing multigenerational development of diabetes within their family.

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Qualitative_research Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Qualitative_research Idioma: En Ano de publicação: 2022 Tipo de documento: Article